Foray bioscience

Cambridge, United States Founded: 2022 • Age: 4 yrs
Developer of wood products using biotechnology

About Foray bioscience

Foray bioscience is a Real Estate & Construction company based in Cambridge (United States) founded in 2022. It operates in the Real Estate & Construction and Chemicals & Materials sectors. Foray bioscience has raised $3.41 million across 2 funding rounds from investors including United States Department of Agriculture, ReGen Ventures and Engine Ventures. Its focus areas include Real Estate and Construction Tech, Construction Tech, Building Materials and Advanced Building Materials. Its competitors include Trex, TimberHP and Park Aerospace.

Company details

Developer of wood products using biotechnology. The company is involved in developing new biotechnologies to produce wood products without cutting down trees. Using concepts in plant cell culture, materials science, and tissue engineering it claims to create alternatives to tree-sourced goods.

  • Headquarters Cambridge, United States
  • Sectors
    Real Estate & Construction
    Chemicals & Materials
  • Website foraybio.com
  • Social LinkedIn
Key Metrics

Funding Insights of Foray bioscience

Foray bioscience has successfully raised a total of $3.41M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $3.41 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $3.41M
  • Total Rounds 2
  • Last Round Seed β€” $3.41M
  • First Round $179,965

    (Jul 2023)

  • Investors Count 6

All 2 funding rounds of Foray bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2024$3.41MSeed–ReGen Ventures
Jul 2023$179,965Grant––
Valuation history

6 investors in total: 6 institutional.

Investors in Foray bioscience

Foray bioscience has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include United States Department of Agriculture, ReGen Ventures and Engine Ventures.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
ReGen Ventures is focused on investing in regenerative technologies.
regen.vcByron Bay, Australia
Early-stage technology startups are funded by Engine Ventures venture capital.
engineventures.comCambridge, United States
Superorganism is recognized as a venture firm focused on biodiversity.
superorganism.comSan Francisco, USA
Funds sustainable startups in climate tech for environmental impact.
1987sig-ssi.comBala Cynwyd, United States
Understorey Ventures is focused on impact investments for planetary health.
2022understorey.ventures
Leadership is provided on agriculture, food, and rural development matters.
1862usda.gov
Premium access

Investor details for Foray bioscience

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Foray bioscience

4 people are tracked at Foray bioscience (2 in leadership, 2 in team).

NameRoleGroup
Ashley Beckwith
Founder And CEOLeadership
Nico Hawley-Weld
Head Of Research & DevelopmentLeadership
Jane Downer
Research Fellow, AI & MLTeam
Samson Karben
Research EngineerTeam
Premium access

Complete people profiles for Foray bioscience

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Foray bioscience

3 dated milestones of Foray bioscience across 2 years, from founding to its latest funding, stage changes and deals.

  1. Founded Foray bioscience is founded.
  2. Funding First funding round of $180K.
  3. Funding Latest funding round, Seed, of $3.4M.

Competitors of Foray bioscience

Foray bioscience has 3 listed competitors in our database. They include Trex, TimberHP and Park Aerospace.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
trex.com1996Winchester, United States1,765
Architectural services for decking and outdoor structures are offered.
timberhp.com2017Belfast, United States
Developer of wood fibre insulation for the residential and light commercial construction markets
parkaerospace.com1954Melville, United States
Advanced composite materials are developed and manufactured for aerospace structures.
Premium access

Detailed competitors of Foray bioscience

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Foray bioscience

The website of Foray bioscience (foraybio.com) receives about 2.9K visits a month.

  • Monthly visits
    2.9K

    ▲ 25.5% vs previous month

Top companies in Construction & Building Tech

3 companies that operate in the same segment as Foray bioscience (Construction & Building Tech) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
SaaS project management software is provided for construction professionals.
2003Carpinteria, California, United StatesUSD 406.15 MUSD 1.32 B4,927
Business management software is offered for home service providers.
2007Glendale, California, United StatesUSD 1.1 BUSD 960.97 M3,049
Cloud-based positioning solutions are offered for industrial sectors.
1978Sunnyvale, California, United StatesUSD 3.59 B12,100
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Foray Bioscience

Premium access

Complete news archive for Foray bioscience

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Foray bioscience

Foray bioscience was founded in 2022 and raised its 1st funding round 1 year after it was founded.

Foray bioscience is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.

Foray bioscience is a funded company, having raised a total of $3.41M across 2 funding rounds to date. The company's 1st funding round was a Grant of $179.97K, raised on Jul 2023.

Developer of wood products using biotechnology. The company is involved in developing new biotechnologies to produce wood products without cutting down trees. Using concepts in plant cell culture, materials science, and tissue engineering it claims to create alternatives to tree-sourced goods.

Foray bioscience's top competitors include Trex, Park Aerospace and TimberHP.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available